# PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Study · id `cardio:ct-nct04149535` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04149535](<https://clinicaltrials.gov/study/NCT04149535>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04149535

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3000 participants.

## Technical summary

Registry record NCT04149535. Randomized; no masking; primary purpose treatment. Start 2020-02-07 (actual); primary completion 2022-02-01 (actual). Results posted on 2023-02-02.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3000 participants (enrolled count; ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Started: 2020-02-07 (actual) (ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Primary completion: 2022-02-01 (actual) (ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Completion: 2022-02-01 (actual) (ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Results first posted: 2023-02-02 (ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Countries: United States; Australia; Denmark; France; Germany; Italy (ClinicalTrials.gov record NCT04149535, source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04149535-2023-02-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement
- Acronym: PROTECTED TAVR
- Condition: Stroke
- Intervention (Device): Sentinel® Cerebral Protection System
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement (`cardio:pubmed-36121045`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial (`cardio:pubmed-39471309`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a2e66a000d6e498d58e673eecd646d099dbe4b2652af9410f826aeaa6eb2efbf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
